The selection of aptamers specific for membrane molecular targets

A growing number of RNA aptamers have been selected experimentally using the SELEX combinatorial approach, and these aptamers have several advantages over monoclonal protein antibodies or peptides with respect to their applications in medicine and nanobiotechnology. Relatively few successful selections have been reported for membrane molecular targets, in contrast to the situation with non-membrane molecular targets. This review compares the procedures and techniques used in selections against membrane proteins and membrane lipids. In the case of membrane proteins, the selections were performed against soluble protein fragments, detergent-membrane protein mixed micelles, whole cells, vesicles derived from cellular membranes, and enveloped viruses. Liposomes were used as an experimental system for the selection of aptamers against membrane lipids. RNA structure-dependent aptamer binding for rafts in lipid vesicles was reported. Based on the selected aptamers against DOPC and the amino acid tryptophan, a specific passive membrane transporter composed of RNA was constructed. The determination of the selectivity of aptamers appears to be a crucial step in a selection, but has rarely been fully investigated. The selections, which use whole cells or vesicles derived from membranes, can yield aptamers not only against proteins but also against membrane lipids.

• Publication year

  2010

• Venue

  Cellular & Molecular Biology Letters

• Publication date

  2010-06-28

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2478/s11658-010-0023-3PMID 20585890PMCID 6275783
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Simple, recurring RNA binding sites for L-arginine.

  2010cited by this paper
• Life from an RNA World: The Ancestor Within

  2010cited by this paper
• The development and testing of aptamers for cancer.

  2009cited by this paper
• Selection, characterization, and application of DNA aptamers for the capture and detection of Salmonella enterica serovars.

  2009cited by this paper
• The Structural Basis for Recognition of the PreQ0 Metabolite by an Unusually Small Riboswitch Aptamer Domain*♦

  2009cited by this paper
• Technical and biological issues relevant to cell typing with aptamers.

  2009influential reference
• Cell-specific aptamer probes for membrane protein elucidation in cancer cells.

  2008cited by this paper
• Aptamer-facilitated biomarker discovery (AptaBiD).

  2008cited by this paper
• Aptamer-based biosensors

  2008cited by this paper
• Complex target SELEX.

  2008cited by this paper
• RNA Aptamers Targeting the Carboxyl Terminus of KRAS Oncoprotein Generated by an Improved SELEX with Isothermal RNA Amplification

  2007cited by this paper
• A riboswitch selective for the queuosine precursor preQ1 contains an unusually small aptamer domain

  2007cited by this paper
• Aptamers as molecular recognition elements for electrical nanobiosensors

  2007cited by this paper
• Aptamer Directly Evolved from Live Cells Recognizes Membrane Bound Immunoglobin Heavy Mu Chain in Burkitt's Lymphoma Cells*S

  2007influential reference
• DNA Aptamers That Bind to MUC1 Tumour Marker: Design and Characterization of MUC1-Binding Single-Stranded DNA Aptamers

  2006cited by this paper
• RNA aptamers selectively modulate protein recruitment to the cytoplasmic domain of beta-secretase BACE1 in vitro.

  2006influential reference
• Specific RNA binding to ordered phospholipid bilayers

  2006cited by this paper
• Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.

  2006cited by this paper
• NMR solution structures of LNA (locked nucleic acid) modified quadruplexes

  2006cited by this paper
• An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits haemagglutinin-mediated membrane fusion.

  2006cited by this paper
• Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface.

  2006cited by this paper
• Modulation of oncogenic transcription and alternative splicing by beta-catenin and an RNA aptamer in colon cancer cells.

  2006cited by this paper
• Aptamers evolved from live cells as effective molecular probes for cancer study

  2006cited by this paper
• Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase

  2005cited by this paper
• Aptamers against extracellular targets for in vivo applications.

  2005cited by this paper
• Unusually short RNA sequences: design of a 13-mer RNA that selectively binds and recognizes theophylline.

  2005cited by this paper
• A membrane transporter for tryptophan composed of RNA.

  2004cited by this paper
• In vitro evolution of RNA aptamers recognizing carcinogenic aromatic amines.

  2004cited by this paper
• A DNA Aptamer Prevents Influenza Infection by Blocking the Receptor Binding Region of the Viral Hemagglutinin*

  2004cited by this paper
• A Small Aptamer with Strong and Specific Recognition of the Triphosphate of ATP

  2004cited by this paper
• A Complex Target

  2003cited by this paper
• Aptamers That Recognize the Lipid Moiety of the Antibiotic Moenomycin A

  2003cited by this paper
• Visualization of membrane RNAs.

  2003cited by this paper
• Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3

  2003influential reference
• Phenylalanine-Binding RNAs and Genetic Code Evolution

  2002cited by this paper
• Generation of RNA aptamers to the G-protein-coupled receptor for neurotensin, NTS-1.

  2002cited by this paper
• In Vitro Selection of RNA Aptamers That Bind to Cell Adhesion Receptors of Trypanosoma cruzi and Inhibit Cell Invasion*

  2002cited by this paper
• Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.

  2002influential reference
• Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein*

  2001cited by this paper
• Binding and disruption of phospholipid bilayers by supramolecular RNA complexes

  2001cited by this paper
• Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels

  2001cited by this paper
• The structural basis for molecular recognition by the vitamin B 12 RNA aptamer

  2000cited by this paper
• RNAs that bind and change the permeability of phospholipid membranes.

  1999cited by this paper
• Combinatorial selection of high affinity RNA ligands to live African trypanosomes.

  1999cited by this paper
• Isoleucine:RNA sites with associated coding sequences.

  1998cited by this paper
• High affinity ligands from in vitro selection: complex targets.

  1998cited by this paper
• In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptor.

  1998cited by this paper
• RNA aptamers that specifically bind to a K Ras-derived farnesylated peptide.

  1997cited by this paper
• Interlocking structural motifs mediate molecular discrimination by a theophylline-binding RNA

  1997cited by this paper
• Calcium-dependent oligonucleotide antagonists specific for L-selectin.

  1996cited by this paper
• An RNA pocket for an aliphatic hydrophobe

  1994cited by this paper
• Three small ribooligonucleotides with specific arginine sites.

  1993cited by this paper
• Selection of single-stranded DNA molecules that bind and inhibit human thrombin

  1992cited by this paper
• Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

  1990cited by this paper
• In vitro selection of RNA molecules that bind specific ligands

  1990cited by this paper
• A specific amino acid binding site composed of RNA.

  1988cited by this paper
• Bolaamphiphiles form ultrathin, porous and unsymmetric monolayer lipid membranes

  1986cited by this paper
• A titration method for bovine trypsin.

  1969cited by this paper
• Pollen-grains in the Air

  1874cited by this paper

• Small extracellular vesicles: connecting early life exposure outcomes to air pollution during pregnancy to early childhood health

  2025cites this paper
• Peptide-based CE-SELEX enables convenient isolation of aptamers specifically recognizing CD20-expressing cells.

  2024cites this paper
• Selection of bifunctional RNAs with specificity for arginine and lipid membranes

  2024cites this paper
• Aptamer-Based Imaging of Polyisoprenoids in the Malaria Parasite

  2023cites this paper
• Clinical Theranostics Trademark of Exosome in Glioblastoma Metastasis.

  2023cites this paper
• Emerging roles of extracellular vesicle-associated non-coding RNAs in hypoxia: Insights from cancer, myocardial infarction and ischemic stroke

  2022cites this paper
• Specific binding of VegT mRNA localization signal to membranes in Xenopus oocytes.

  2021cites this paper
• Advances in aptasensor technology.

  2020cites this paper
• Binding of RNA Aptamers to Membrane Lipid Rafts: Implications for Exosomal miRNAs Transfer from Cancer to Immune Cells

  2020cites this paper
• Exosomal miRNAs: Novel players in viral infection.

  2020cites this paper
• The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring

  2019cites this paper
• Selection of Membrane RNA Aptamers to Amyloid Beta Peptide: Implications for Exosome-Based Antioxidant Strategies

  2019cites this paper
• Contribution of Extracellular Vesicles in Rebuilding Injured Muscles

  2019cites this paper
• 1 Aptamers Selected for Recognizing Amyloid 2 β-protein — A Case for Cautious Optimism 3

  2018cites this paper
• Aptamers Selected for Recognizing Amyloid β-Protein—A Case for Cautious Optimism

  2018cites this paper
• Calcium phosphate-based nanosystems for advanced targeted nanomedicine

  2018cites this paper
• Understanding extracellular vesicle diversity – current status

  2018cites this paper
• Von Willebrand Factor and Cardiovascular Disease: From a Biochemical Marker to an Attractive Therapeutic Target.

  2017cites this paper
• Asymmetric RNA Distribution among Cells and Their Secreted Exosomes: Biomedical Meaning and Considerations on Diagnostic Applications

  2017cites this paper
• Novel Antibody-Targeted Liposomes for the Treatment of Solid Tumors

  2016cites this paper
• The Cocaine-Binding Aptamer: A Thermodynamic and Structural Overview of Specific and Non-Specific Binding Interactions

  2016cites this paper
• Aptamers: new arrows to target dendritic cells

  2016cites this paper
• Novel antisense therapeutics delivery systems: In vitro and in vivo studies of liposomes targeted with anti-CD20 antibody.

  2015cites this paper
• The dynamics of the RNA world: insights and challenges

  2015cites this paper
• Super-resolution imaging for cell biologists: concepts, applications, current challenges and developments.

  2015cites this paper
• Advanced technologies for improved discovery of DNA aptamers and characterization of biologic affinity reagents

  2015cites this paper
• Aptasensors for viral diagnostics

  2015cites this paper
• Selection of LNA-containing DNA aptamers against recombinant human CD73.

  2015cites this paper
• Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges

  2015cites this paper
• Mechanisms of RNA loading into exosomes

  2015cites this paper
• Prebiotic systems chemistry: new perspectives for the origins of life.

  2014cites this paper
• Cellular and Molecular Applications of Super-resolution Microscopy

  2014cites this paper
• Probing Biological Samples in High-Resolution Microscopy: Making Sense of Spots

  2014cites this paper
• Nucleic acid aptamer for microvesicle

  2014cites this paper
• Membrane potential-dependent binding of polysialic acid to lipid monolayers and bilayers

  2013cites this paper
• The strongest resistance of Staphylococcus aureus to erythromycin is caused by decreasing uptake of the antibiotic into the cells

  2012cites this paper
• Aptamer-labeled PLGA nanoparticles for targeting cancer cells

  2012cites this paper
• Aptamer-Nanoparticle Bioconjugates for Drug Delivery

  2012cites this paper
• Target binding improves relaxivity in aptamer–gadolinium conjugates

  2012cites this paper
• The effect of long-chain bases on polysialic acid-mediated membrane interactions.

  2011cites this paper